Zydus receives final approval from USFDA for Prucalopride Tablets
Prucalopride is prescribed for chronic idiopathic constipation
Prucalopride is prescribed for chronic idiopathic constipation
Quest will now offer dialysis-related clinical testing services to independent dialysis clinics
Tamsulosin, an alpha-1 adrenergic receptor blocker, combined with Dutasteride, a dual 5- alpha-reductase inhibitor, is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) in adult men
This is the group’s first NoC approval in Canada
Vasograin Plus represents a major advancement in the treatment of migraine
cSCC is one of the most common cancers in the U.S. and globally
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
Subscribe To Our Newsletter & Stay Updated